Pedmarqsi 80 mg/ml, Infusionslösung

7680701940015 CH-70194 Infusionslösung

Associated product:

PEDMARQSI 80 mg/ml sol perf 80 mg 1 pce

No image available

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Infusionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
01/05/2026
Patient information leaflet
Français
01/05/2026
Patient information leaflet
Italien
01/05/2026
Summary of Product Characteristics
Allemand
01/05/2026
Summary of Product Characteristics
Français
01/05/2026
Summary of Product Characteristics
Italien
01/05/2026

Detailed composition

Substance Quantity Type Category
natrii thiosulfas anhydricus
80.0 MG Substance Wirkstoff (Principe actif)
acidum boricum
0.25 MG Substance HBESI
natrii hydroxidum
- Substance HNIDK
acidum hydrochloridum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
23.27 MG Substance HBESI

Authorization holder

Norgine AG

6005 Luzern

Authorization information

Swissmedic authorization number
70194
Drug name
Pedmarqsi, Infusionslösung
Galenic form
LSINF
ATC Code
V03AB06
Authorization status
Z
Dispensing category
A
First authorization
18/03/2026
Authorization expiration date
17/03/2031
IT Number
15.01.0.
Domain
Human medicine
Field of application
Vorbeugung einer durch Cisplatin verursachten Ototoxizität bei Kindern im Alter von 1 Monat bis < 18 Jahren

Package details

Description (FR)
PEDMARQSI 80 mg/ml sol perf 80 mg 1 pce
Description (DE)
PEDMARQSI 80 mg/ml Inf Lös 80 mg 1 Stk
Market launch
01/05/2026
Narcotic (BTM)
No
Buy us a coffee Explore the data